S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10

Medibank Private Stock Forecast, Price & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume10.99 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield3.98%

Receive MPL News and Ratings via Email

Sign-up to receive the latest news and ratings for Medibank Private and its competitors with MarketBeat's FREE daily newsletter.

About Medibank Private

Medibank Private Limited, an integrated healthcare company, provides private health insurance and health solutions in Australia. The company operates through two segments, Health Insurance and Medibank Health. The Health Insurance segment offers private health insurance products, including hospital cover that provides members with health cover for hospital treatments; and ancillary cover, which offers members with health cover for healthcare services, such as dental, optical, and physiotherapy. This segment also provides health insurance products to overseas visitors and overseas students. The Medibank Health segment offers health management and telehealth services to government and corporate customers, as well as distributes travel, life, and pet insurance products. Medibank Private Limited underwrites its health insurance products under the Medibank and ahm brands. The company was founded in 1976 and is based in Docklands, Australia.


See More Headlines

Industry, Sector and Symbol

Insurance - Diversified
Year Founded

Sales & Book Value

Annual Sales
$7.03 billion
Book Value
A$0.69 per share





Next Earnings Date
Not Optionable


Overall MarketRank

1.27 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Medibank Private (ASX:MPL) Frequently Asked Questions

What stocks does MarketBeat like better than Medibank Private?

Wall Street analysts have given Medibank Private a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Medibank Private wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How often does Medibank Private pay dividends? What is the dividend yield for Medibank Private?

Medibank Private announced a Final dividend on Thursday, August 26th. Stockholders of record on Wednesday, September 29th will be paid a dividend of 0.069 per share on Wednesday, September 29th. This represents a dividend yield of 1.94%. The ex-dividend date is Tuesday, September 7th. This is a positive change from Medibank Private's previous Final dividend of A$0.06.
View Medibank Private's dividend history

Is Medibank Private a good dividend stock?

Medibank Private pays an annual dividend of A$0.14 per share and currently has a dividend yield of 3.98%. MPL has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of Medibank Private is 87.50%. Payout ratios above 75% are not desirable because they may not be sustainable.
View Medibank Private's dividend history.

Who are Medibank Private's key executives?

Medibank Private's management team includes the following people:
  • Mr. David Koczkar B.Com., BCom, PGDipFinance, MAICD, CEO & MD
  • Mr. Mark Rogers B.Sc., BEng (Hons), BSc, Group Exec. & CFO
  • Mr. John Goodall B.Sc., BSc (Hons), Group Exec. of Technology & Operations
  • Ms. Mei Ramsay B.A., L.L.B., L.L.M., BA, LLB, LLM, Group Exec. of Legal, Governance & Regulatory Affairs and Company Sec.
  • Ms. Kylie Bishop B.A., BA (Hons) Psy, MOrgPsych, Group Exec. of People & Culture
  • Dr. Andrew Wilson M.M., MBBS, MM, FRANZCP, FACHSE, Group Exec. of Healthcare & Strategy
  • Mr. Peter Kopanidis, Sr. Exec. of Corp. Fin.
  • Colette Campbell, Sr. Exec. of Investor Relations
  • Emily Ritchie, Sr. Exec. of External Affairs
  • Ms. Fiona Le Brocq, Acting Chief Customer Officer

What other stocks do shareholders of Medibank Private own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medibank Private investors own include Woodside Petroleum (WPL), Wesfarmers (WES), National Australia Bank (NAB), (KLR), Japara Healthcare (JHC), G8 Education (GEM), Aveo Group (AOG), Ardent Leisure Group (ALG) and Asaleo Care (AHY).

What is Medibank Private's stock symbol?

Medibank Private trades on the ASX under the ticker symbol "MPL."

How much money does Medibank Private make?

Medibank Private has a market capitalization of $0.00 and generates $7.03 billion in revenue each year.

How many employees does Medibank Private have?

Medibank Private employs 3,536 workers across the globe.

What is Medibank Private's official website?

The official website for Medibank Private is www.medibank.com.au.

How can I contact Medibank Private?

The company can be reached via phone at 61 3 8622 5780.

This page was last updated on 10/24/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.